Abstract:PurposeThe aim of this study was to assess the technical feasibility, efficacy, and complications of CT-guided interstitial brachytherapy for treating inoperable non-small cell lung cancer (NSCLC).Materials and methodsTwenty one patients were included in this prospective study. The median age was 72.6 years (57–85). Tumors were treated with brachytherapy that was positioned under CT-fluoroscopy. The treatment planning system (TPS) was used preoperatively to reconstruct three dimensional images of the tumor and to calculate the estimated seed number and distribution. The median matched peripheral dose (MPD) was 130Gy (range, 100–160Gy). All procedures were performed under local anesthesia. A follow-up CT was performed 6 weeks later and every 3 months post implantation.ResultsFollow-up period was 2–30 months. The mean diameter of the 21 lung tumors was 4.6cm (range, 2.8–6.5cm). The response rate of pain relief was 83.3% (10/12). The pain-free duration was 0–12 months (median: 6 months; 95% CI: 3–9 months). Overall responding rate (CR+PR) for this group of patients was 71.4%. Local tumor control rate was 85.7%. Six (28.6%) patients died as a result of primary tumor progression; thirteen (61.9%) patients died of multi-organ failure or other metastases. Two (9.5%) patients survived to follow-up. At the time of analysis, the median survival time for all patients was 10 months (95% CI: 6.6–13.4 months), with 1 year and 2 year survival rates were 42.4% and 6.5%, respectively. Median survival time for stage II, stage III, and stage IV was 20 months, 9 months, and 8 months, respectively. No major complications were observed. Minor complications (19%) included mild pneumothorax (n=1), hemosputum (n=1), pleural effusion (n=1), and localized skin erythema (n=1). None of these complications required further treatment, although hospital discharge was delayed. No 125I seeds migrated to other tissues or organs.ConclusionMinimally invasive CT-guided interstitial brachytherapy is safe, useful, less complicated and considered as a palliative treatment option for inoperable non-small cell lung cancer.

Brachytherapy by Percutaneous Paracentesis Implantation of Iodine-125 Seeds for Lung Cancer

Brachytherapy by CT-guided Percutaneous Paracentesis Implantation of Iodine-125 Seeds for Lung Cancer

Brachytherapy by CT-guided Percutaneous Paracentesis Implantation of Iodine-125 Seed for Lung Cancer in Old Patients

Preliminary Clinical Efficacy of Iodine-125 Seed Implantation for the Treatment of Advanced Malignant Lung Tumors

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

Trans-Bronchoscope 125i Radioactive Seeds Implantation in Patients with Pulmonary Atelectasis Induced by Lung Cancer - A Pilot Study

CT-guided percutaneous 125 I seed implantation brachytherapy in patients with stage Ⅲ non-small-cell lung cancer

Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non–small cell lung cancer—A meta-analysis

Clinical efficacy of CT-guided ~(125)I seed implantation therapy for advanced lung cancer

Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma

CT-guided iodine-125 brachytherapy is an effective palliative treatment for the right lower paratracheal lymph nodes metastasis previously treatment failure

A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment

CT-guided Interstitial Implantation of ~(125)I Seed for Lung Cancer

Feasibility and Clinical Value of CT-guided (125)I Brachytherapy for Bilateral Lung Recurrences from Colorectal Carcinoma.

125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments.

I-125 Brachytherapy In The Palliation Of Painful Bone Metastases From Lung Cancer After Failure Or Rejection Of Conventional Treatments

Radiation Physics, Quality Control, and Quality Assurance of Lung Cancer Brachytherapy with 125I Particles

CT-guided Interstitial Brachytherapy of Inoperable Non-Small Cell Lung Cancer.

The efficacy and safety of percutaneous CT-guided iodine-125 brachytherapy combined with standard chemotherapy and brachytherapy alone for lung malignant nodule: a retrospective comparative cohort study

Percutaneous Computed Tomography-Guided Combined Endonasal Bronchoscope-Guided Permanent Iodine-125 Implantation as Therapy Central Lung Cancer

Computed Tomography-Guided Implantation of 125I Radioactive Seeds in Patients with Malignant Airway Compression Induced by Advanced Lung Cancer: Effectiveness and Safety in 40 Patients